Find An Allergist / Immunologist | Pollen Counts | Journal of Allergy and Clinical Immunology | Annual Meeting  
Site Map   Contact   Home   

Search   
Members
Member Resources

AAAAI News

AAAAI eNews

AAAAI Job Placement Center
Promoting your Practice

Order Public Education Materials

Disease Management/
Ask the Expert


Allergy, Asthma & Immunology Education and Research Trust (ART)

Journal of Allergy and
Clinical Immunology


2007 Accomplishments

Annual Meeting

Executive Staff Contacts

Online Membership Directory


AAAAI Organizational Structure »

Academy News: July 2003

Lay Organizations

Immune Deficiency Foundation
40 West Chesapeake Avenue
Suite 308
Towson, MD 21204
Phone 800-296-4433
www.primaryimmune.org

IDF Awards 2003 Research Grants
The Immune Deficiency Foundation initiated an annual research grants program in 2000 for researchers pursuing studies in primary immune deficiency diseases. The annual grants program is a national competition and proposals are peer-reviewed to ensure excellence. IDF is pleased to announce the recipients of its 2003 research grant awards:

Donna L. Bratton, MD
National Jewish Medical and Research Center
Denver, Colorado
“Defective Phosphatidylserine Exposure During Apoptosis of Neutrophils in Chronic Granulomatous Disease Inhibits Phagocytic Recognition and Engulfment and Results in Enhanced Inflammation”

Stefan Feske, MD
The Center for Blood Research, Inc.
Boston, Massachusetts
“Identifying Mutations in Calcium Release Activated (CRAC) Channels in T Cells from Patients with Sever Combined Immunodeficiency”

IDF is currently accepting research proposals for the 2004 Research Grants Program. The proposal deadline is November 1, 2003. For more information, contact IDF at 800-296-4433 or idf@primaryimmune.org

IDF Launches New Website
Check out www.primaryimmune.org! The Immune Deficiency Foundation launched a new Web site in April 2003 celebrating Primary Immune Deficiency Awareness Week. The new Web site features the most current and up-to-date information available for patients and families affected by primary immune deficiency diseases. The Web site also offers expanded information on health insurance, a new section on genetics and inheritance of primary immune deficiency diseases, and an “In the News” section highlighting research headlines, IDF events and initiatives and other important information. In addition, links to professional resources are available.

IDF’s new Web site features password protected discussion forums. Patients and family members affected by primary immune deficiency diseases can log on to chat and share their experiences with others. The current forum topics include:

  • Living as an Adult with Primary Immune Deficiency

  • Parenting a Child with Primary Immune Deficiency

  • Experiences with Immune Globulin Therapy

  • Coping with a New Diagnosis

  • Teen Talk: Teens living with Primary Immune Deficiency

We are constantly updating the site with local program developments, research and scientific programs, and progress on our public policy initiatives. Log on to www.primaryimmune.org today!

Food Allergy & Anaphylaxis Network
10400 Eaton Place, Suite 107
Fairfax, VA 22030
Phone 800-929-4040
Fax (703) 691-2713
www.foodallergy.org

The 6th Annual Food Allergy Awareness Week (FAAW) was held May 11-17, and we celebrated the first World Food Allergy Awareness Day on May 11. Forty-four states and the District of Columbia recognized FAAW via proclamation this year. FAAN and the other members of the international Food Allergy & Anaphylaxis Alliance (FAAA) worked to educate the public during this time.

Schools
FAAN is preparing a guidance document for managing food allergies during a school “lock down” due to emergency situations. Among the topics covered will be food selection to avoid common allergens and medication storage.

Free materials for schools regarding food allergy management are available on the FAAN Web site: www.foodallergy.org.

Pediatric Food Allergy Supplement
Last year, FAAN co-hosted a meeting with many of the world’s leading experts in food allergy to help pediatricians better understand the diagnosis and treatment of food allergy.

The information presented at this meeting is being published as a supplement to the June issue of Pediatrics, a publication of the American Academy of Pediatrics, and will be distributed to more than 60,000 pediatricians across the country.

Mariel C. Furlong Awards
AAAAI members James Banks, MD, FAAAAI, and Kenneth Kray, MD, were the recipients of this year’s Mariel C. Furlong Award for Making a Difference in the Health Professional category. They were nominated by their patients, and selected based on their significant contributions to food allergy awareness, education and advocacy. A total of 21 individuals received MCF Awards this year. Other award categories include Community Service, School and Food Service. Nominations for this annual award will reopen in October.

Special Events
The FAAN Golf Classic, scheduled for August 11 at Ellington Ridge Country Club in Connecticut, will feature cocktails, dinner and a silent auction after the tournament. FAAN will also host a movie premiere at Disneyland Resort, CA on September 28. Proceeds from both events will be used to support education and research activities. 

Anaphylaxis Update
A 32-year-old man with a known shrimp allergy recently died after eating a meal that may have been contaminated with shrimp. The man’s wife said he was very careful, but he didn’t carry his epinephrine.

A 12-year-old girl with a known peanut allergy died after eating an egg roll. No other information has been confirmed at this time.

Please remind your patients to be careful and be sure they have prescribed medication with them at all times.

Asthma and Allergy Foundation of America
1233 20th St. NW, Suite 402
Washington, DC 20036
Phone (202) 466-7643
Fax (202) 466-8940
www.aafa.org

Research: Finding the U.S. Allergy Capital™
The Foundation recently completed a research project to identify the nation’s top 50 Allergy Capitals™ the worst cities for people with allergies, and Louisville, KY, rated highest on the list. This first annual listing is part of a nationwide campaign to help consumers recognize, prevent and safely treat allergy symptoms. The 2003 Allergy Capitals™ were identified and ranked based on key objective environmental and medical factors in each market, including:

  • Environmental factors - The average recorded pollen levels over the past seven years and the length of the peak season for the most offensive pollen types.

  • Medical factors - The number of antihistamine prescriptions written per capita over the past year and the current number of board certified allergists per capita.

Each factor was “weighted,” in consultation with medical and research experts, to reflect its relative importance as an indicator of allergy severity. Then the weighted factors in each market were tallied, compared and ranked to come up with the final Allergy Capital™listing.

Louisville, KY, achieved the highest rating primarily because of its extremely high average pollen counts over the years. However, physicians in the Louisville metropolitan area also prescribe a much higher-than-average number of antihistamine prescriptions per capita than many of the other cities on the list. This indicates that people who live in the area are severely affected by the high concentration of allergens in the air. Fortunately, according to the Foundation’s research results, the number of Board Certified allergists per capita in the Louisville area is consistent with the national average.

Education: Nationwide public education campaign begins
To celebrate the Foundation’s 50th anniversary, we have launched a national, multi-year public education campaign under the theme, For Life Without Limits, to educate Americans about advances in research, diagnosis, prevention and treatment of asthma and other allergic diseases. For Life Without Limits is more than a theme, it’s a new mission for the Foundation, our Chapters and Educational Support Groups, to help improve the quality of life for millions of people affected by these diseases. The Foundation believes that people with asthma and allergies can significantly improve their lives and health though education and proper health management. The public awareness campaign will involve national awareness research, public service ads, PR campaigns, strategic partnerships and more.

Advocacy: Support on Capitol Hill
The Foundation advocates for new, safe and effective drugs that mitigate the personal and social consequences of asthma. We recently offered a voice of support to encourage a U.S. Food and Drug Administration (FDA) committee to recommend approval of a new asthma drug. The Foundation invited several asthma patients to provide personal testimony at the FDA’s Pulmonary-Allergy Drugs Advisory Committee’s (PADAC) May meeting about the benefits of approving the new therapy, Omalizumab (Xolair), as a treatment for moderate-to-severe allergic asthma in adults and adolescents. The resulting PADAC recommendation unanimously supported approval of the drug, and the FDA is expected to make a final decision later this summer.

Allergy & Asthma Network Mothers of Asthmatics
2751 Prosperity Ave., Suite 150
Fairfax, VA 22031
Phone 800-878-4403
Fax (703) 573-7794
www.aanma.org
E-mail aanma@aol.com

Asthma Awareness Day Capitol Hill 2003
Asthma Awareness Day Capitol Hill 2003 (AADCH) was a huge success! Allergy & Asthma Network Mothers of Asthmatics (AANMA) hosted its sixth annual AADCH national education event in Washington, DC, on May 7, 2003. AADCH provides a public forum for lawmakers to address issues affecting people with asthma and allergies. Highlights of this year’s event include the introduction of legislation that will save children’s lives and benefit all families of students with asthma and anaphylaxis.

More than 300 people attended the public Allergy & Asthma Expo at Union Station. The Expo featured 25 exhibits on allergies and asthma from nonprofit organizations, government agencies and corporate sponsors. The Expo featured free asthma screenings including pulmonary function testing and consultations with board-certified allergists. Children’s entertainment included Clifford the Big Red Dog, Ernie of Sesame Street, Zoey and Light Buddy, Pulmi, and Uncle Sam Stiltwalker. Goody bags with Aller-Rx products and Pizzeria Uno coupons, refreshments, and door prizes donated by Staples and America Restaurant rounded out the event.

In the afternoon, attention turned to the U.S. House of Representatives. At our press conference in the Cannon House Office Building, Representative Cliff Stearns (R-FL) and Representative Patrick Kennedy (D-RI) announced they would introduce legislation known as ASTHMA 2003 that afternoon. Representatives Joe Barton, Ed Towns, and Nita Lowey (AADCH 2003 Congressional Co-Chairs) also spoke in support of the legislation.

ASTHMA 2003, officially known as H.R. 2023, provides incentives to states to develop statutes allowing students to carry and self-administer prescribed lifesaving asthma and anaphylaxis medications while at school. The bill has been referred to the Energy & Commerce committee.

AANMA continues to celebrate the success of AADCH 2003; however, there is much work to be done over the next year. Help all students with allergies and asthma by contacting your Federal elected officials and asking them to support H.R. 2023!

New Asthma and Pregnancy Brochure Available in Spanish
Check out the Spanish version of AANMA’s "Breathing for Two: A Guide to Asthma During Pregnancy.” “Respirando Por Dos” is coauthored by James Kemp, MD, FAAAAI and Michael Schatz, MD, MS, FAAAAI and AANMA President Nancy Sander. The brochure is endorsed by the AAAAI and the Association of Asthma Educators and sponsored by a grant from AstraZeneca. For a free copy of this brochure call 800-878-4403 while supplies last. The booklet also can be downloaded from our Web site at www.breatherville.org/medicalcenter.

<back>



© 1996-2008 · All Rights Reserved · American Academy of Allergy Asthma & Immunology